Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.
about
A humanized antibody that binds to the interleukin 2 receptorT Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T CellsCytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli.Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro.Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats.Cardiac allograft survival in mice treated with IL-2-PE40.Monoclonal antibodies in renal transplantation: a review.Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genesInterleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion proteinAnti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.2006 Homer W. Smith Lecture: taming T cellsIL-2 pathway blocking in combination with anti-CD154 synergistically establishes mixed macrochimerism with limited dose of bone marrow cells and prolongs skin graft survival in miceT cell activation antigens: therapeutic implications.Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies.Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease.Cell receptor specific targeted toxins: genetic construction and characterization of an interleukin 2 diphtheria toxin-related fusion protein.
P2860
Q24600912-F76A3724-6275-4AFA-9F28-77333B8BFF83Q26823613-EA50A727-2615-4CB2-8220-4C2FDC644F81Q33560732-732BC670-3597-47DE-9D2D-60503CEE0BB1Q33645011-C03C4873-83D4-4FD7-83FF-C22B2EA3BDD3Q33810506-7E7EC59E-3426-413E-869C-48159E00BF53Q33829471-317F8F62-971E-4389-A0E7-784E254C10B4Q33835646-B20B13C9-19EC-4C19-80C4-6C9B3B6531E9Q35451349-9B6A67EF-B33F-4005-8FEB-B684A05C6E6EQ35782480-033AF236-36E9-49B8-A209-942B82D054F4Q36354517-B523C731-E625-4A58-A4F1-248CD2A3A634Q36357690-95FCD4D2-05D4-4E30-9D19-952F1AE12D5EQ37105565-10FD55C4-E67B-4B89-802C-77056D9DEAF2Q37292014-01CC10E2-ED07-4993-859F-BE067A800948Q39231492-A17C58DB-CA94-4A8A-867F-EC56F7EF4A56Q44665379-89BE82A9-273E-4535-ABF0-AA813D2873B2Q54268586-F2419908-4E16-42E7-A98B-7880BF23FF95Q54755828-7FF91F45-544D-48F7-9558-C5C1F6CCA75E
P2860
Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Therapy with monoclonal antibo ...... e allograft rejection in rats.
@ast
Therapy with monoclonal antibo ...... e allograft rejection in rats.
@en
type
label
Therapy with monoclonal antibo ...... e allograft rejection in rats.
@ast
Therapy with monoclonal antibo ...... e allograft rejection in rats.
@en
prefLabel
Therapy with monoclonal antibo ...... e allograft rejection in rats.
@ast
Therapy with monoclonal antibo ...... e allograft rejection in rats.
@en
P2093
P2860
P356
P1476
Therapy with monoclonal antibo ...... e allograft rejection in rats.
@en
P2093
J W Kupiec-Weglinski
N L Tilney
T Diamantstein
P2860
P304
P356
10.1073/PNAS.83.8.2624
P407
P577
1986-04-01T00:00:00Z